The development of new genetic-editing technology offers cannabis companies a cost-effective way to make specific changes to marijuana and hemp plants – such as more disease resistance – without creating a genetically modified organism (GMO).
The technology, known as Crispr-Cas9, will allow the cannabis industry to build new, improved plants that promise to introduce hardiness and efficiencies into cultivation. That, in turn, could boost profits.
Developed by Emmanuelle Charpentier and Jennifer A. Doudna, the Crispr-Cas9 gene-editing technique revolutionizes genetic engineering in many fields, including medicine and agriculture.
They were awarded the 2020 Nobel Prize in chemistry for their work.
To read more, click on https://mjbizdaily.com/genetic-editing-offers-marijuana-and-hemp-companies-a-way-to-improve-plant-strains/?utm_medium=email&utm_source=newsletter&utm_campaign=MJD_20210223_News_Daily